Medical Department, Viborg Regional Hospital, DK-8800 Viborg, Denmark.
BMC Cancer. 2009 Nov 21;9:407. doi: 10.1186/1471-2407-9-407.
The xenobiotic transporters, Multidrug Resistance 1 (MDR1/ABCB1) and Breast Cancer Resistance Protein (BCRP/ABCG2) may restrict intestinal absorption of various carcinogens, including heterocyclic amines (HCA) and polycyclic aromatic hydrocarbons (PAH). Cyclooxygenase-2 (COX-2) derived prostaglandins promote gastrointestinal carcinogenesis, affecting angiogenesis, apoptosis, and invasiveness.The aim of this study was to investigate if polymorphisms in these genes were associated with risk of colorectal cancer (CRC), and to investigate possible interactions with lifestyle factors such as smoking, meat consumption, and NSAID use.
The following polymorphisms were analyzed; a synonymous MDR1 C3435T (rs1045642) in exon26, G-rs3789243-A in intron3, the functional BCRP C421A (rs2231142), the two COX-2 A-1195G (rs689466) and G-765C (rs20417) in the promoter region, and the COX-2 T8473C (rs5275) polymorphisms in the 3'-untranslated region. The polymorphisms were assessed together with lifestyle factors in a nested case-cohort study of 359 cases and a random cohort sample of 765 participants from the Danish prospective Diet, Cancer and Health study.
Carriers of the variant allele of MDR1 intron 3 polymorphism were at 1.52-fold higher risk of CRC than homozygous wild type allele carriers (Incidence rate ratio (IRR) = 1.52, 95% Confidence Interval (CI): 1.12-2.06). Carriers of the variant allele of MDR1 C3435T exon 26 had a lower risk of CRC than homozygous C-allele carriers (IRR = 0.71 (CI:0.50-1.00)). There was interaction between these MDR1 polymorphisms and intake of red and processed meat in relation to CRC risk. Homozygous MDR1 C3435T C-allele carriers were at 8% increased risk pr 25 gram meat per day (CI: 1.00-1.16) whereas variant allele carriers were not at increased risk (p for interaction = 0.02). COX-2 and BCRP polymorphisms were not associated with CRC risk. There was interaction between NSAID use and MDR1 C3435T and COX-2 T8473C (p-values for interaction 0.001 and 0.04, respectively).
Two polymorphisms in MDR1 were associated with CRC risk and there was interaction between these polymorphisms and meat intake in relation to CRC risk. Our results suggest that MDR1 polymorphisms affect the relationship between meat and CRC risk.
外源性物质转运蛋白多药耐药蛋白 1(MDR1/ABCB1)和乳腺癌耐药蛋白(BCRP/ABCG2)可能会限制包括杂环胺(HCA)和多环芳烃(PAH)在内的多种致癌物质的肠道吸收。环氧化酶-2(COX-2)衍生的前列腺素促进胃肠道癌的发生,影响血管生成、凋亡和侵袭。本研究旨在调查这些基因的多态性是否与结直肠癌(CRC)的风险相关,并研究其与生活方式因素(如吸烟、肉类消费和 NSAID 使用)的可能相互作用。
分析了以下多态性:MDR1 外显子 26 中的同义 C3435T(rs1045642)、内含子 3 中的 G-rs3789243-A、功能性 BCRP C421A(rs2231142)、COX-2 启动子区域中的两个 A-1195G(rs689466)和 G-765C(rs20417)以及 COX-2 3′-非翻译区的 T8473C(rs5275)多态性。在丹麦前瞻性饮食、癌症和健康研究的一项嵌套病例对照研究中,对 359 例病例和 765 名随机队列参与者的生活方式因素进行了评估。
与野生型纯合子携带者相比,MDR1 内含子 3 多态性的变异等位基因携带者 CRC 的风险高 1.52 倍(发病率比(IRR)= 1.52,95%置信区间(CI):1.12-2.06)。与 MDR1 C3435T 外显子 26 中的纯合 C-等位基因携带者相比,MDR1 C3435T 变异等位基因携带者 CRC 的风险较低(IRR = 0.71(CI:0.50-1.00))。这些 MDR1 多态性与红肉类和加工肉类的摄入量与 CRC 风险之间存在交互作用。杂合子 MDR1 C3435T C-等位基因携带者每天每摄入 25 克肉的风险增加 8%(CI:1.00-1.16),而变异等位基因携带者则没有增加的风险(交互作用 p 值= 0.02)。COX-2 和 BCRP 多态性与 CRC 风险无关。COX-2 T8473C 和 NSAID 使用与 MDR1 C3435T 之间存在交互作用(交互作用的 p 值分别为 0.001 和 0.04)。
MDR1 中的两个多态性与 CRC 风险相关,并且这些多态性与肉类摄入与 CRC 风险之间存在交互作用。我们的结果表明,MDR1 多态性影响了肉类与 CRC 风险之间的关系。